Join to view full profile
3400 Spruce Street1018 DonnerPhiladelphia, PA 19104
Phone+1 215-662-3041
Fax+1 215-349-5843
Dr. Dubroff is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Jacob Dubroff, MD, specializes in Nuclear Medicine and is based in Philadelphia, PA. He completed his medical education at SUNY Upstate Medical University, earning both an MD and a PhD in Medicine and Neuroscience. He has been a Clinical Instructor at the Hospital of the University of Pennsylvania since 2010. His expertise encompasses positron emission tomography, single photon emission computerized tomography, clinical and biomedical research, and advanced cardiac imaging. Dr. Dubroff has published numerous studies in journals such as the Journal of Nuclear Medicine and the European Journal of Nuclear Medicine and Molecular Imaging. He has also conducted clinical trials on topics related to nicotine addiction and radiotracer evaluation. He has received CMS Meaningful Use Stage 1 Certification from EpicCare for two consecutive years.
Education & Training
Penn Medicine2010
SUNY Upstate Medical UniversityMD, PhD, Medicine, Neuroscience, 1998 - 2006
SUNY Upstate Medical UniversityClass of 2006
University of PennsylvaniaBAS, BA, Biomedical Engineering, History and Sociology of S, 1993 - 1997
Certifications & Licensure
NJ State Medical License 2014 - 2027
PA State Medical License 2010 - 2026
American Board of Nuclear Medicine Nuclear Medicine
Nuclear Regulatory CommisionAuthorized User
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Study of Radiotracer [18F]Fluortriopride ([18F]FTP) by PET/CT Start of enrollment: 2015 Mar 27
- Evaluation of D3 Receptor Occupancy Using FLUORTRIOPRIDE ([18F]FTP) PET/CT
- Nicotinic Hepatic Metabolism on Neuroreceptor Substrates of Nicotine Addiction Start of enrollment: 2018 Jun 28
Publications & Presentations
PubMed
- Prospective exploratory pilot study of 18 F-FMISO PET/CT for assessing tumor hypoxia in soft tissue sarcomas.Ronnie Sebro, Ashley M Fuller, T S Karin Eisenger-Matheson, Christina Dulal, Austin R Pantel
Cancer Imaging. 2026-06-20 - Hippocampal Volume and Brain Tau Pathology in Opioid Use Disorder: Associations with Non-Fatal Opioid Overdose.Delaney McKinstry, Zhenhao Shi, Astrid P Ramos-Rolón, Jeffrey Phillips, Sandhitsu Das
Addiction Neuroscience. 2026-06-01 - 2 citationsDiscordance of Dopaminergic Dysfunction and Subcortical Atrophy by α-Synuclein Status in Sporadic and Genetic Parkinson's Disease.Michael Tran Duong, Sandhitsu R Das, Pulkit Khandelwal, Joaquin A Vizcarra, Yue Li
Movement Disorders. 2026-05-01
Press Mentions
Opioid Overdose Medications May Be More Effective in Women, According to New PET Imaging StudyJuly 24th, 2025- Dr. Jacob Dubroff: How Brain Imaging Is Changing the Way We Diagnose Alzheimer’sJune 9th, 2025
- Whole-Body PET Shows How Naloxone Blocks OpioidsMay 9th, 2025
External Links
- UPenn Radiologyhttps://www.pennmedicine.org/departments-and-centers/department-of-radiology
- UPenn PET Centerhttps://www.pennmedicine.org/departments-and-centers/department-of-radiology/radiology-research/core-facilities/pet-center
- Professional Home Pagehttp://www.med.upenn.edu/apps/faculty/index.php/g334/p6489091
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
